EUVIMEDEUVIMED entdecken
Open Access

Plasma Metabolome Predicts Aortic Stiffness and Future Risk of Coronary Artery Disease and Mortality After 23 Years of Follow‐Up in the General Population

Filip Ottosson iD, Gunnar Engström iD, Marju Orho-Melander iD, Olle Melander iD, Peter M Nilsson iD, Madeleine Johansson iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.033442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Filip Ottosson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences in Malmö Lund University Malmö Sweden. Hauptthemen laut MEDLINE: Vascular Stiffness, Coronary Artery Disease, Metabolome, Metabolomics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Increased aortic stiffness (arteriosclerosis) is associated with early vascular aging independent of age and sex. The underlying mechanisms of early vascular aging remain largely unexplored in the general population. We aimed to investigate the plasma metabolomic profile in aortic stiffness (vascular aging) and associated risk of incident cardiovascular disease and mortality. Methods and Results We included 6865 individuals from 2 Swedish population‐based cohorts. Untargeted plasma metabolomics was performed by liquid‐chromatography mass spectrometry. Aortic stiffness was assessed directly by carotid‐femoral pulse wave velocity (PWV) and indirectly by augmentation index (AIx@75). A least absolute shrinkage and selection operator (LASSO) regression model was created on plasma metabolites in order to predict aortic stiffness. Associations between metabolite‐predicted aortic stiffness and risk of new‐onset cardiovascular disease, cardiovascular mortality, and all‐cause mortality were calculated. Metabolite‐predicted aortic stiffness (PWV and AIx@75) was positively associated particularly with acylcarnitines, dimethylguanidino valeric acid, glutamate, and cystine. The plasma metabolome predicted aortic stiffness (PWV and AIx@75) with good accuracy (R 2 =0.27 and R 2 =0.39, respectively). Metabolite‐predicted aortic stiffness (PWV and AIx@75) was significantly correlated with age, sex, systolic blood pressure, body mass index, and low‐density lipoprotein. After 23 years of follow‐up, metabolite‐predicted aortic stiffness (PWV and AIx@75) was significantly associated with increased risk of new‐onset coronary artery disease, cardiovascular mortality, and all‐cause mortality.

Conclusions

Aortic stiffness is associated particularly with altered metabolism of acylcarnitines, cystine, and dimethylguanidino valeric acid. These metabolic disturbances predict increased risk of new‐onset coronary artery disease, cardiovascular mortality, and all‐cause mortality after more than 23 years of follow‐up in the general population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular StiffnessCoronary Artery DiseaseMetabolomeMetabolomicsHumansMaleFemaleSwedenMiddle AgedAgedFollow-Up StudiesRisk AssessmentBiomarkersRisk FactorsCarotid-Femoral Pulse Wave VelocityAdultTime FactorsIncidencePulse Wave AnalysisCarnitine

Stichwörter der Autor:innen

aortic stiffnessbiomarkerscoronary artery diseaseepidemiologymetabolomicsmortalitystroke

Substanzen

BiomarkersacylcarnitineCarnitine

Autor:innen und Institutionen

  • Department of Clinical Sciences in Malmö Lund University Malmö Sweden.
  • Section for Clinical Mass Spectrometry Statens Serum Institut Copenhagen Denmark.
  • Department of Internal Medicine Skåne University Hospital Malmö Sweden.
  • Department of Cardiology Skåne University Hospital Malmö Sweden.

ORCID-Profile: Filip Ottosson, Gunnar Engström, Marju Orho-Melander, Olle Melander, Peter M Nilsson, Madeleine Johansson

Zitieren

APA

Ottosson, F., Engström, G., Orho-Melander, M., Melander, O., Nilsson, P. M., & Johansson, M. (2024). Plasma Metabolome Predicts Aortic Stiffness and Future Risk of Coronary Artery Disease and Mortality After 23 Years of Follow‐Up in the General Population. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033442

Vancouver

Ottosson F, Engström G, Orho-Melander M, Melander O, Nilsson PM, Johansson M. Plasma Metabolome Predicts Aortic Stiffness and Future Risk of Coronary Artery Disease and Mortality After 23 Years of Follow‐Up in the General Population. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.033442

BibTeX
@article{Ottosson2024,
  author = {Ottosson, Filip and Engström, Gunnar and Orho-Melander, Marju and Melander, Olle and Nilsson, Peter M and Johansson, Madeleine},
  title = {Plasma Metabolome Predicts Aortic Stiffness and Future Risk of Coronary Artery Disease and Mortality After 23 Years of Follow‐Up in the General Population},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.033442}
}
Kostenlos starten →